Circadian heart rate and blood pressure variability considered for research and patient care

International Journal of Cardiology

Volumn 87, Issue 1, 2003, Pages 9-28

  Singh, Ram B ^a   Cornélissen, Germaine ^b   Weydahl, Andi ^c   Schwartzkopff, Othild ^b   Katinas, George ^b   Otsuka, Kuniaki ^b   Watanabe, Yoshihiko ^d   Yano, Shoki ^e   Mori, Hideki ^f   Ichimaru, Yuhei ^g   Mitsutake, Gen ^h   Pella, Daniel ⁱ   Fanghong, Lu ^j   Zhao, Ziyan ^j   Rao, Reema S ^a   Gvozdjakova, Anna ^k   Halberg, Franz ^b  

^a Medical Hospital and Research Center Moradabad   (India)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF TROMSØ   (Norway)

^d TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^e HOKKAIDO INSTITUTE OF PUBLIC HEALTH   (Japan)

^f AOMORI PREFECTURAL CENTRAL HOSPITAL   (Japan)

^g School of Science and Engineering   (Japan)

^h UNIVERSITY OF MANITOBA   (Canada)

ⁱ P J AFÁRIK UNIVERSITY   (Slovakia)

^j Institute of Materia Medica   (China)

^k Pharmacobiochemical Laboratory   (Slovakia)

more..

Author keywords

Blood pressure variability; Circadian variation; Heart rate variability; Sudden death

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ESTROGEN; OMEGA 3 FATTY ACID;

AGE; ANESTHESIA; ATHEROSCLEROSIS; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CIRCADIAN RHYTHM; COLD EXPOSURE; CORONARY ARTERY DISEASE; DEATH; DIABETES MELLITUS; EMOTION; EXERCISE; GENDER; HEAD INJURY; HEART ARRHYTHMIA; HEART FAILURE; HEART HYPERTROPHY; HEART INFARCTION; HEART PROTECTION; HEART RATE VARIABILITY; HEART RHYTHM; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; INSULIN RESISTANCE; KIDNEY DISEASE; MEDICAL RESEARCH; MEDITATION; MORBIDITY; MORTALITY; OBESITY; OVERNUTRITION; PATIENT CARE; POLLUTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SITTING; SLEEP DEPRIVATION; SMOKING; STANDING; STROKE; SUDDEN DEATH; THERMAL EXPOSURE; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

EID: 0037213465     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(02)00308-X     Document Type: Article

References (161)

1. Singh R.B. Can nutrition influence heart rate and blood pressure variability. Proceedings of the first international symposium on chronoastrobiology and chronotherapy. Biomed Pharmacother J. 55:2001;7-18.
2. Halberg F., Cornélissen G., Halberg J., et al. Circadian hyper-amplitude-tension, CHAT: a disease risk syndrome of antiaging medicine. JAAM. 1:1998;239-259.
3. Morris K. New day dawns for research on circadian rhythms. Lancet. 353:1999;990.
4. Halberg F. Temporal coordination of physiologic function. Cold Spring Harbor Symp Quant Biol. 25:1960;289-310.
5. Halberg F., Cornélissen G., Otsuka K., et al. Cross spectrally coherent 10.5 and 21 year biological and physical cycles, magnetic storms and myocardial infarctions. Neuroendocrinol Lett. 21:2000;233-258.
6. Halberg F., Halberg E., Barnum C.P., Bittner J.J. Physiologic 24-h periodicity in human beings and mice, the lighting regimen and daily routine. Withrow R.B. Photoperiodism and related phenomena in plants and animals. Ed. publ. no. 55. 1959;803-878 American Association for the Advancement of Science, Washington, DC.
7. Halberg F., Halberg E., Halberg J. Collateral-interacting hierarchy of rhythm coordination at different organization levels, changing schedules and aging. Suda M., Hayaishi O., Nakagawa H. Biological rhythms and their central mechanisms. Naito Foundation. 1979;421-434 Elsevier North-Holland Biomedical, Amsterdam. see also discussion pp. 435-438.
8. Pennisi E. Multiple clocks keep time in fruit fly tissues. Science. 278:1997;1560-1561.
9. Plautz J.D., Kaneko M., Hall J.C., Kay S.A. Independent photoreceptive circadian clocks throughout Drosophila. Science. 278:1997;1632-1635.
10. Kyriacou C.P., Hall J.C. Circadian rhythm mutations in Drosophila melanogaster affect a short-term fluctuation in the male's courtship song. Proc Natl Acad Sci USA. 77:1980;6929-6933.
11. Cornélissen G., Halberg F. Introduction to chronobiology. Medtronic chronobiology seminar #7, April. 1994;52. Library of Congress Catalog Card #94-060580; URL [accessed 1994] http://www.msi.umn.edu/~halberg/.
12. Vaidya A.B., Bhatt M.A. Chronobiology of ischemic heart disease events: relevance of ancient insights in human lifestyle. J Assoc Phys India. 47:1999;629-630.
13. Mehta S.R., Das S., Karloopia S.D., Mathur P., Dham S.K., Raghunathan D. The circadian pattern of ischemic heart disease in Indian population. J Assoc Phys India. 46:1998;767-777.
14. Charaka Samhita (Charka, 600 BC). 1981;Chaukhambha Orientalia, Varanasi, Delhi. translated by Sharma PV.
15. Sushruta Samhita (Sushruta, 600 BC). vol. 1-3:1999;Sanskrit Series Office, Varanasi. translated by Bhisagratna Chaukhambha.
16. Atharva-Veda-Samhita (written c. 3000-5000 BC). Translated with a critical and exegetical commentary by William Dwight Whitney; revised and brought nearer to completion and edited by Charles Rockwell Lannan. Harvard Oriental Series. Motilal Banarsidass, Delhi, 1984.
17. Frey S. Der Tod des Menschen in seinen Beziehungen zu den Tages und Jahreszeiten. Dtsch Zeit Chirurgie. 218:1929;366-369.
18. Pell S., D'Allonzo C.A. Acute myocardial infarction in a large industrial population. J Am Med Assoc. 185:1963;831-838.
19. Smolensky M., Halberg F., Sargent F. II: Chronobiology of the life sequence. Itoh S., Ogata K., Yoshimura H. Advances in climatic physiology. 1972;281-318 Igaku Shoin, Tokyo.
20. Reinberg A., Gervais P., Halberg F., et al. Mortalité des adultes: rythmes circadiens et circannuels dans un hôpital parisien et en France. Nouv Presse Méd. 2:1973;289-294.
21. Wennerblom B., Lurje L., Karsson T., Tygesen H., Vahisalo R., Hjamarson A. Circadian variation of heart rate variability and the rate of autonomic change in the morning hours in healthy subjects and angina patients. Int J Cardiol. 79:2001;61-69.
22. Churisna S.K., Ganelina I.E. On the distribution of incidence of acute myocardial infarction within a 24-hour period. Kardiologia. 15:1975;115-118.
23. Christ M., Seyffart K., Wehling M. Attenuation of heart rate variability in postmenopausal women on progestin containing hormone replacement therapy. Lancet. 353:1999;1939-1940.
24. La Rovere M.T., Bigger J.T. Jr., Marcus F.I., et al. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet. 351:1998;478-484. see comments.
25. Bigger J.T. Jr., Fleish J.L., Steinman R.C., Rolnitzsky L.M., Kleiger R.E., Rottman J.N. Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation. 85:1992;164-171.
26. Rosano G.M., Patrizi R., Leonardo F., et al. Effect of estrogen replacement therapy in heart rate variability and heart rate in healthy postmenopausal women. Am J Cardiol. 80:1996;815-817.
27. Muller J.E., Stone P.H., Zoltan G., et al. The MILIS study groups; circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med. 313:1985;1315-1322.
28. Thompson D.R., Blandford R.L., Sutton T.W., Merchant P.R. Time onset of chest pain in acute myocardial infarction. Int J Cardiol. 7:1985;139-146.
29. Peters R.W., Zoble R.G., Liebson P.R., et al. Identification of a secondary peak in myocardial infarction onset 11 to 12 hours after awakening: CAST experience. J Am Coll Cardiol. 2:1993;998-1003.
30. Willich S.N., Goldberg J.G., Maclure M., Petrriello I., Muller J.E. Increased onset of sudden cardiac death in the first 3 hours after awakening. Am J Cardiol. 70:1992;65-68.
31. Hedblad B., Juul M.S., Svensson K., et al. Increased mortality in men with ST segment depression during 24-hour ambulatory long term ECG recording. Eur Heart J. 10:1989;149-158.
32. Becker R.C., Corrao J.M. Circadian variations in cardiovascular disease. Clev Clin J Med. 56:1989;676-680.
33. Tofler G.H., Brezinski D.A., Schafer H.I., et al. Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N Engl J Med. 316:1987;1514-1518.
34. Braunwald E. Unstable angina: an etiologic approach to management. Circulation. 98:1998;2219-2222.
35. Muller J.E., Befler G.H., Stone P.H. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation. 4:1989;733-740.
36. Cornélissen G., Breus T.K., Bingham C., et al. Beyond circadian chronorisk: worldwide circaseptan-circasemiseptan patterns of myocardial infarctions, other vascular events, and emergencies. Chronobiologia. 20:1993;87-115.
37. Cornélissen G., Tamura K., Tarquini B., et al. Differences in some circadian patterns of cardiac arrhythmia, myocardial infarction and other adverse vascular events. Chronobiologia. 21:1994;79-88.
38. Otsuka K. Chronome and Janus-Medicine. Heart rate variability (HRV) and BP variability (BPV) from a viewpoint of chronobiology and ecology. 1998;213 Medical Review, Tokyo.
39. Chen C.H., Ting C.T., Lin S.J., et al. Relation between diurnal variation of blood pressure and left ventricular mass in a Chinese population. Am J Cardiol. 75:1995;1239-1243.
40. Otsuka K., Cornélissen G., Halberg F., Oehlert G. Excessive circadian amplitude increases risk of ischemic stroke and nephropathy. J Med Eng Tech. 21:1997;23-30.
41. Kumagai Y., Shiga T., Sunaga K., Cornélissen G., Ebihara A., Halberg F. Usefulness of circadian amplitude of blood pressure in predicting hypertensive cardiac involvement. Chronobiologia. 19:1992;43-58.
42. Feigin V.L., Nikitin Yu.P., Vinogrodova T.E. Solar and geomagnetic activities: are there associations with stroke occurrence. Cereb Vasc Dis. 7:1997;345-348.
43. Otsuka K., Cornélissen G., Halberg F. Age, gender and fractal scaling in heart rate variability. Clin Sci. 93:1997;299-308.
44. Otsuka K., Cornélissen G., Halberg F. Circadian rhythmic scaling of heart rate variability in health and coronary artery disease. Clin Cardiol. 20:1997;631-638.
45. Watanabe Y., Cornélissen G., Halberg F., et al. Chronobiometric assessment of autogenic training effects upon blood pressure and heart rate. Percept Motor Skills. 83:1996;1395-1410.
46. Tamura K., Kohna I., Saito Y., et al. Antihypertensive individualized therapeutic strategy. Difesa Sociale. 6:1991;109-124.
47. Gallerani M., Portaluppi F., Maida G., et al. Circadian and circa-annual rhythmicity in the occurrence of subarachnoid haemorrhage. Stroke. 27:1996;1793-1797.
48. Manfredini R., Gallerani M., Portaluppi F., Salmi R., Fesim C. Chronobiological patterns of onset of acute cerebrovascular disease. Thromb Res. 88:1997;451-463.
49. Cohen M.C., Rohtla K.M., Lavery C.E., Muller J.E., Mittleman M.A. Metaanalysis of the morning excess of acute myocardial infarction and sudden cardiac death. Am J Cardiol. 79:1997;1512-1516.
50. Singh R.B., Cornélissen G., Siegelova J., Homolka P., Halberg F. About half-weekly (circasemiseptan) pattern in blood pressure and heart rate in men and women of India. Scripta Medica (Brno). 75:2002;125-128.
51. Chen C.H., Cornélissen G., Halberg F., et al. Left ventricular mass index as 'outcome' related to circadian blood pressure characteristics. Scripta Med. 71:1998;183-189.
52. Cornélissen G., Halberg F., Schwartzkopff O., et al. Chronomes, time structures, for chronobioengineering for 'a full life'. Biomed Instrum Technol. 33:1999;152-187.
53. Delyukov A., Gorgo Yu., Cornélissen G., Otsuka K., Halberg F. Natural environmental associations in a 50-day human electrocardiogram. Int J Biometeorol. 45:2001;90-99.
54. Kukreja R.S., Datta B.N., Chakravarti R.N. Catecholamine-induced aggravation of aortic and coronary atherosclerosis in monkeys. Atherosclerosis. 40:1981;291-298.
55. Cugini P., Letizia C., Scarvo D. The circadian rhythmicity of serum angiotensin converting enzyme: its phasic relation with circadian cycle of plasma renin and aldosterone. Chronobiologia. 15:1988;229-232.
56. Cugini P., Scibilia G., Cavallini M., et al. Circadian rhythms of renin activity, aldosterone, angiotensin converting enzyme and cortisol in kidney and heart transplantation. Prog Clin Biol Res. 341A:1990;565-574.
57. Veglio F., Pitrandice R., Ossola M., Vignani A., Angili A. Circadian rhythm of the angiotensin converting enzyme activity in serum of healthy adult subjects. Chronobiologia. 14:1997;21-25.
58. Christensen J.H., Gustenhoff P., Komp E., et al. Effect of fish oil on heart rate variability in survivors of myocardial infarction. Br Med J. 312:1996;677-678.
59. Christensen J.H., Komp E., Aaroe J., et al. Fish consumption, n-3 fatty acids in cell membranes, and heart rate variability in survivors of myocardial infarction with left ventricular dysfunction. Am J Cardiol. 79:1997;1670-1672.
60. Gudbjarnason S. Dynamics of n-3 and n-6 fatty acids in phospholipids of heart muscle. J Intern Med. 225:(Suppl):1989;117-128.
61. Singh R.B., Niaz M.A., Sharma J.P., Kumar R., Rastogi V., Moshiri M. Randomized, double blind, placebo controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction. The Indian experiment of infarct survival. Cardiovasc Drug Ther. 11:1997;485-491.
62. Singh R.B., Wander G.S., Rastogi A., et al. Randomized, double blind, placebo controlled trial of coenzyme Q10 in patients with acute myocardial infarction. Cardiovasc Drug Ther. 12:1998;347-353.
63. Pepe S., Bogdonor K., Hallaq H., Spurgeon H., Leaf A., Lakatta E. Omega-3 polyunsaturated fatty acids modulates dihydropyridine effects on L-type Ca-channels, cytosolic Ca and contraction in adult rat cardiac myocytes. Proc Natl Acad Sci USA. 91:1994;8832-8836.
64. Chin J.P.F. Marine oils and cardiovascular reactivity. Prostaglandins Leukot Essent Fatty Acids. 50:1994;211-222.
65. Christensen J.H., Christensen M.S., Toft E., Dyerberg J., Schmidt E.B. Alpha-linolenic acid and heart rate variability. Nutr Metab Cardiovasc Dis. 10:2000;57-61.
66. Christensen J.H., Skou H.A., Fog L., et al. Marine n-3 fatty acids, wine intake, and heart rate variability in patients referred for coronary angiography. Circulation. 103:2001;651-657.
67. Perini R., Milesi S., Fisher N.M., Pendergast D.R., Veicsteinas A. Heart rate variability during dynamic exercise in elderly males and females. Eur J Appl Physiol. 82:2000;8-15.
68. Duru F., Candinas R., Dziekan G., Goebbels U., Myers J., Dubach P. Effect of exercise training on heart rate variability in patients with new onset left ventricular dysfunction after myocardial infarction. Am Heart J. 140:2000;157-161.
69. Bernardi L., Wdowczyk-Szulc J., Valenti C., et al. Effects of controlled breathing, mental activity and mental stress with or without verbalization on heart rate variability. J Am Coll Cardiol. 35:2000;1462-1469.
70. Garcia-Gonzalez M.A., Vazquez-Seisdedos C., Pallas-Areny R. Variations in breathing patterns increase low frequency contents in HRV spectra. Physiol Meas. 21:2000;417-423.
71. Mortara A., La Rovere M.T., Pinna G.D., Maestri R., Capomolla S., Cobelli F. Non-selective beta-adrenergic blocking agent, carvedilol, improves arterial baroflex gain and heart rate variability in patients with stable chronic heart failure. J Am Coll Cardiol. 36:2000;1612-1618.
72. Kruger C., Landerer V., Zugck C., Ehmke H., Kubler W., Haass M. The bradycardic agent zatebrandine enhances baroreflex sensitivity and heart rate variability in rats early after myocardial infarction. Cardiovasc Res. 45:2000;900-912.
73. Weydahl A., Cornélissen G., Halberg F., Siegelova J., Kumagai Y., Otsuka K. Chronobiologic optimization of exercise physiology and practice guided by heart rate variability. Scripta Med (Brno). 71:1998;215-230.
74. Korkmaz M.E., Muderrisoglu H., Ulucam Ozin B. Effects of spironolactone on heart rate variability and left ventricular systolic function in severe ischemic heart failure. Am J Cardiol. 86:(6):2000;649-653.
75. Paolisso G., Manzella D., Rizzo M.R., et al. Elevated plasma fatty acid concentrations stimulate the cardiac autonomic nervous system in healthy subjects. Am J Clin Nutr. 72:2000;723-730.
76. Singh J.P., Larson M.G., O'Donnell C.J., et al. Association of hyperglycemia with reduced heart rate variability (The Framingham Heart Study). Am J Cardiol. 86:2000;309-311.
77. Lanza G.A., Giordano A., Pristipino C., et al. Relationship between myocardial 123I-metaiodobenzyl-guanidine scientigraphic uptake and heart rate variability in patients with syndrome X. Ital Heart J. 1:2000;221-225.
78. Paolisso G., Manzella D., Montano N., Gambardella A., Varrichio M. Plasma leptin concentrations and cardiac autonomic nervous system in healthy subjects with different body weights. J Clin Endocrinol Metab. 85:2000;1810-1814.
79. Gold D.R., Litonjua A., Schwartz J., et al. Ambient pollution and heart rate variability. Circulation. 101:2000;1267-1273.
80. Coats A.J., Adamopoulos S., Radaelli A., et al. Controlled trial of physical training in chronic heart failure: exercise performance, hemodynamics, ventilation and autonomic function. Circulation. 85:1992;2119-2131.
81. Borer K.T., Cornélissen G., Halberg F. Walking intensity modifies systolic and pulse pressures in postmenopausal women. 2000 Annual Meeting, New Orleans, LA, Nov. 4-9. 2000;1947 Society for Neuroscience. Abstract 728.4.
82. Levine H., Saltzman W., Yankaskas J., Halberg F. Circadian stage-dependent effect of exercise upon blood pressure in clinically healthy men. Chronobiologia. 4:1977;129.
83. Halberg F., Cornélissen G., Katinas G.S., et al. Feedsidewards: intermodulation (strictly) among time structures, chronomes, in and around us, and cosmo-vasculo-neuroimmunity. About ten-yearly changes: what Galileo missed and Schwabe found. NY Acad Sci. 917:2000;348-376.
84. Epstein A.E., Carlson M.D., Fogoros R.N., et al. Classification of death in antiarrhythmia trials. J Am Coll Cardiol. 27:1996;433-442.
85. Kleiger R.E., Miller J.P., Bigger J.T. Jr., Moss A.J. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol. 59:1987;256-262.
86. Franzosi M.G., Sanforo E., de Vita C., et al. Ten-year follow up of the first mega trial testing thrombolytic therapy in patients with acute myocardial infarction. Circulation. 15:1998;2659-2665.
87. Farrell T.G., Bashir Y., Cripps T., et al. Risk stratification for arrhythmic events in post-infarction patients based on heart rate variability, ambulatory electrocardiographic variables and the signal-averaged electrocardiogram. J Am Coll Cardiol. 18:1991;687-697.
88. Copie X., Hnatkova K., Staunton A., Camm A.J., Malik M. Predictive power of increased heart rate versus depressed left ventricular ejection fraction and heart rate variability for risk stratification after myocardial infarction. Results of a 2 year follow up study. J Am Coll Cardiol. 27:1996;270-276.
89. Hartikainen J.E.F., Malik M., Staunton A., Poloniecki J., Camm A.J. Distinction between arrhythmic and nonarrhythmic death after acute myocardial infarction based on heart rate variability, signal-averaged electrocardiogram, ventricular arrhythmias and left ventricular ejection fraction. J Am Coll Cardiol. 28:1996;296-304.
90. Bigger J.T. Jr., Fleiss J.L., Rolnitzky L.M., Steinman R.C. Frequency domain measures of heart period variability to assess risk of late myocardial infarction. J Am Coll Cardiol. 21:1993;729-736.
91. Bigger J.T. Jr., Steinman R.C., Rolnitzky L.M., et al. Power law behaviour of R-R-interval variability in healthy middle-aged persons, patients with recent acute myocardial infarction and patients with heart transplants. Circulation. 93:1996;2142-2151.
92. Perkiomaki J.S., Huikuri H.V., Koistinen J.M., et al. Heart rate variability and dispersion of QT interval in patients with vulnerability to ventricular tachycardia and ventricular fibrillation after previous myocardial infarction. J Am Coll Cardiol. 30:1997;1331-1338.
93. Valkama J.O., Huikuri H.V., Koistinen M.J., et al. Relation between heart rate variability and spontaneous and induced ventricular arrhythmias in patients with coronary artery disease. J Am Coll Cardiol. 25:1995;437-443.
94. Huikuri H.V., Seppanen T., Koistinen M.J., et al. Abnormalities in beat-to-beat dynamics of heart rate before the spontaneous onset of life-threatening ventricular tachyarrhythmias in patients with prior myocardial infarction. Circulation. 93:1996;1836-1844.
95. Shusterman V., Aysin B., Gottipaty V., et al. Autonomic nervous system activity and the spontaneous initiation of ventricular tachycardia. J Am Coll Cardiol. 32:1998;1891-1899.
96. Vybiral T., Glaeser D.H., Goldberger A.L., et al. Conventional heart rate variability analysis of ambulatory electrocardiographic recordings fails to predict imminent ventricular fibrillation. J Am Coll Cardiol. 22:1993;557-565.
97. Carandente O., Halberg F., Cornélissen G. Two circadian and an infradian rhythm in human cardiac arrhythmia? Prog Clin Biol Res. 227B:1987;159-165.
98. Halberg F., Tamura K., Cornélissen G. Chronobioengineering toward a cost-effective quality health care. Frontiers Med Biol Eng. 6:1994;83-102.
99. Halberg F., Cornélissen G., Otsuka K., et al. Rewards in practice from recycling heart rate, ectopy, ischemia, and blood pressure information. J Med Eng Technol. 21:1997;174-184.
100. Schwartz P.J., La Rovere M.T., Vanoli E. Autonomic nervous system and sudden cardiac death: experimental basis and clinical observations for post-myocardial infarction risk stratification. Circulation. 85:(Suppl I):1992;77-91.
101. Schwartz P.J., Billman G.E., Stone H.L. Autonomic mechanisms in ventricular fibrillation induced by myocardial ischemia during exercise in dogs with a healed myocardial infarction. An experimental preparation for sudden cardiac death. Circulation. 69:1984;780-790.
102. Airaksinen K.E.J., Ikaheimo M.J., Huikuri H.V., et al. Responses of heart rate variability to coronary occlusion during coronary angioplasty. Am J Cardiol. 72:1993;1026-1030.
103. Bonnemier H., Hartmann F., Wiegant U.K., et al. Heart rate variability in patients with acute myocardial infarction undergoing primary coronary angioplasty. Am J Cardiol. 85:(7):2000;815-820.
104. Airaksinen K.E.J., Ikaheimo M.J., Linnaluoto M.K., et al. Gender difference in autonomic and hemodynamic reactions to abrupt coronary occlusion. J Am Coll Cardiol. 31:1998;301-306.
105. Airaksinen K.E.J., Ylitalo A., Niemela M., et al. Heart rate variability and occurrence of ventricular arrhythmias during abrupt coronary occlusion. Am J Cardiol. 83:1999;1000-1005.
106. Lucreziotti S., Gavazzi A., Scelsi L., et al. Five-minute recording of heart rate variability in severe chronic heart failure: correlates with right ventricular function and prognostic implications. Am Heart J. 139:2000;1088-1095.
107. Tsuiji H., Venditti F.J., Manders E.S., et al. Reduced heart rate variability and mortality risk in an elderly cohort. The Framingham Heart Study. Circulation. 90:1994;878-883.
108. Tsuiji H., Larson M.G., Venditti F.J. Jr., et al. Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study. Circulation. 94:1996;2850-2855.
109. Huikuri H.V., Makikallio T.H., Airaksinen K.E.J., et al. Power-law relationship of heart rate variability as a predictor of mortality in the elderly. Circulation. 97:1998;2030-2036.
110. Bloch-Thomsen P.-E., Huikuri H., Kober L., et al. Lessons from the Nordic ICD pilot study. Lancet. 353:1999;2130-2132.
111. Pruvat E., Thonet G., Vesin J.M., et al. Heart rate dynamics at the onset of ventricular tachyarrhythmias as retrieved from implantable cardioverter-defibrillators in patients with coronary artery disease. Circulation. 101:2000;2398-2404.
112. Stein P.K., Domitrovich P.P., Kleiger R.E., Schechtman K.B., Rottman J.N. Clinical and demographic determinants of heart rate variability in patients post myocardial infarction: insights from the cardiac arrhythmia suppression trial (CAST). Clin Cardiol. 23:2000;187-194.
113. Otsuka K., Cornélissen G., Halberg F., et al. Predictive value of blood pressure dipping and swinging with regard to vascular disease risk. Clin Drug Invest. 11:1996;20-31.
114. Jensen-Urstad M., Samad B.A., Jensen-Ursted K., Hulting J., Ruiz H., Bouvier F., Hojer J. Risk assessment in patients with acute myocardial infarction. J Intern Med. 249:2001;527-537.
115. Burger A.J., Aronson D. Activity of neurohormonal system and its relationship to autonomic abnormalities in decompensated heart failure. J Card Fail. 7:2001;122-128.
116. Nolan J., Batin P.D., Andrews R., et al. Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-Heart). Circulation. 98:1998;1510-1516.
117. Soejima K., Akaishi M., Meguro T., et al. Age-adjusted heart rate variability as an index of the severity and prognosis of heart failure. Jpn Circ J. 64:(1):2000;32-38.
118. Roch F., Pichot V., Da Costa A., et al. Chronotopic incompetence response to exercise in congestive heart failure, relationship with cardiac autonomic status. Clin Physiol. 21:2001;335-342.
119. Kubo T., Ando S., Picton P., et al. Atrial natriuretic peptide augments the variability of sympathetic nerve activity in human heart failure. J Hypertens. 19:2001;619-626.
120. Martini G., Rabbia F., Gastaldi L., et al. Heart rate variability and left ventricular diastolic function in patients with borderline hypertension with and without left ventricular hypertrophy. Clin Exp Hypertens. 23:2001;77-87.
121. Aronson D., Mittleman M.A., Burger A.J. Interleukin-6 levels are inversely correlated with heart rate variability in patients with decompensated heart failure. J Cardiovasc Electrophysiol. 12:2001;301-302.
122. Huikuri H.V., Jokinen V., Syvanne M., et al. Heart rate variability and progression of coronary atherosclerosis. Arterioscler Thromb Vasc Biol. 19:1999;1979-1985.
123. Beere P.A., Glagov S., Zarins C.K. Retarding effect of lowered heart rate on coronary atherosclerosis. Science. 226:1984;180-182.
124. Kaplan J.R., Manuck S.B., Adams M.R., et al. Inhibition of coronary atherosclerosis by propranolol on behaviorally predisposed monkeys fed an atherogenic diet. Circulation. 86:1987;1364-1374.
125. Kaplan J.R., Manuck S.B., Clarkson T.B. The influence of heart rate on coronary atherosclerosis. J Cardiovasc Pharm. 10:(Suppl 2):1987;S100-102.
126. Caro C.G., Fitz-Gerald J.M., Schroter R.C. Arterial wall shear and distribution of early atheroma in man. Nature. 223:1969;1159-1161.
127. Zuanetti G., Neilson J.M.M., Latini R., et al. Prognostic significance of heart rate variability in post-myocardial infarction patients in the fibrinolytic era. The GISSI-2 results. Circulation. 94:1996;432-436.
128. Myerburg R.J., Kessler K.M., Castellanos A. Sudden cardiac death. Structure, function, and time-dependence of risk. Circulation. 85:(Suppl I):1992;12-20.
129. Goldman S., Johnson G., Cohn J.N., et al. Mechanism of death in heart failure: the vasodilator-heart failure trials. Circulation. 87:(Suppl VI):1993;2431-2433.
130. Dresing J.J., Natale A. Congestive heart failure treatment: the pacing approach. Heart Fail Rev. 6:2001;15-25.
131. Cornélissen G., Halberg F., Burioka N., Perfetto F., Tarquini R., Bakken E.E. Do plasma melatonin concentrations decline with age. Am J Med. 109:2000;343-344. [Letter to the editor re: Zeitzer JM, Daniels JE, Duffy JF et al. Do plasma melatonin concentrations decline with age? Am J Med 1999;107:432-436].
132. Reinberg A., Ghata J., Halberg F., et al. Rythmes circadiens du pouls, de la pression artérielle, des excrétions urinaires en 17-hydroxycorticostéroïdes, catécholamines et potassium chez l'homme adulte sain, actif et au repos. Ann Endocrinol (Paris). 31:1970;277-287.
133. Descovich G.C., Montalbetti N., Kühl J.F.W., Rimondi S., Halberg F., Ceredi C. Age and catecholamine rhythms. Chronobiologia. 1:1974;163-171.
134. Germanó G., Ferri C., Cammarella I., et al. Circadian blood pressure, heart rate and endocrine variations in young healthy and MESOR-hypertensive men. Yoshikawa M., Uono M., Tanabe H., Ishikawa S. New trends in autonomic nervous system research: basic and clinical interpretations, selected proceedings 20th international congress on neurovegetative research, Tokyo, September 10-14. 1990;576-580 Excerpta Medica, Amsterdam.
135. Heart rate variability, standards of measurement, physiological interpretation and clinical use. Circulation. 93:1996;1043-1065.
136. Malik M., Hnatkova K., Camm A.J. Practicality of postinfarction risk assessment based on time-domain measurement of heart rate variability. Malik M., Camm A.J. Heart rate variability. 1995;393-406 Futura, Armonk, NY.
137. Goldberger A.L. Non-linear dynamics for clinicians: chaos theory, fractals and complexity at the bedside. Lancet. 347:1996;1312-1314.
138. Goldberger A.L., West B.J. Fractals in physiology and medicine. Yale J Biol Med. 60:1987;421-435.
139. Makikallio T.H., Ristimae T., Airaksinen E.K.J., et al. Heart rate dynamics in patients with stable angina pectoris and utility of fractal and complexity measures. Am J Cardiol. 81:1998;27-31.
140. Makikallio T.H., Koistinen M.J., Tulppo M.P., et al. R-R interval dynamics before the spontaneous onset of ventricular fibrillation. Am J Cardiol. 83:1999;880-884.
141. Camm A.J., Karam R., Pratt C.M. The azimilide post-infarct survival evaluation (ALIVE) trial. Am J Cardiol. 81:1998;35D-39D.
142. Nisam S., Mower M. ICD trials: an extraordinary means of determining patients risk? PACE. 21:1998;1341-1346.
143. Malik M., Camm A.J., Janse M.J., et al. Depressed heart rate variability identifies postinfarction patients who might benefit from prophylactic treatment with amiodarone: a substudy of EMIAT (The European Myocardial Infarct Amiodarone Trial). J Am Coll Cardiol. 35:2000;1263-1275.
144. Storck N., Ericson M., Lindblad L., Jensen-Urstad M. Automatic computerised analysis of heart rate variability with digital filtering of ectopic beats. Clin Physiol. 21:2001;15-24.
145. Yee K.M., Pringle S.D., Struthers A. Circadian variation in the effects of aldosterone blockade on heart rate variability and QT dispersion in congestive heart failure. J Am Coll Cardiol. 37:2001;1800-1807.
146. Aronson D., Burger A.J. Effect of beta-blockade on autonomic modulation of heart rate and neurohormonal profile in decompensated heart failure. Ann Noninvasive Electrocardiol. 6:2001;98-106.
147. Lin L.Y., Lin J.L., Du C.C., Lai L.P., Tseng Y.Z., Huang S.K. Reversal of deteriorated fractal behavior of heart rate variability by beta-blocker therapy in patients with advanced congestive heart failure. Cardiovasc Electrophysiol. 12:2001;33-35.
148. Ulgen M.S., Akdemir O., Toprak N. The effects of trimetazidine on heart rate variability and signal-averaged electrocardiography in the early period of acute myocardial infarction. Int J Cardiol. 77:2001;255-262.
149. Kumagai Y., Cornélissen G., Lykken D.T., et al. In vitro and in vivo evidence for built-in features of the human heart rate chronome. Cornélissen G., Halberg E., Bakken E., Delmore P., Halberg F. Toward Phase Zero Preclinical and Clinical Trials: Chronobiologic Designs and Illustrative Applications. 2nd Extended Ed. Medtronic Chronobiology Seminar Series, #6. 1993;47-83 University of Minnesota. Part I.
150. Zaslavskaya R.M. 2nd ed. Chronodiagnosis and chronotherapy of cardiovascular diseases. 1993;397 Medicina, Moscow. Translation into English from Russian.
151. Cornélissen G., Engebretson M., Johnson D., et al. The week, inherited in neonatal human twins, found also in geomagnetic pulsations in isolated Antarctica. Biomed Pharmacother. 55:(Suppl 1):2001;32-50.
152. Halberg F., Cornélissen G., Sothern R.B., et al. International geographic studies of oncological interest on chronobiological variables. Kaiser H. Neoplasms - comparative pathology of growth in animals, plants and man. 1981;553-596 Williams and Wilkins, Baltimore.
153. Kawasaki T., Ueno M., Uezono K., et al. Differences and similarities among circadian characteristics of plasma renin activity in healthy young women in Japan and the United States. Am J Med. 68:1980;91-96.
154. Wetterberg L., Halberg F., Halberg E., et al. Circadian characteristics of urinary melatonin from clinically healthy women at different civilization disease risk. Acta Med Scand. 220:1986;71-81.
155. Halberg F., Cornélissen G., Conti C., et al. The pineal gland and chronobiologic history: mind and spirit as feedsidewards in time structures for prehabilitation. Bartsch C., Bartsch H., Blask D.E., Cardinali D.P., Hrushesky W.J.M., Mecke W. The pineal gland and cancer: neuroimmunoendocrine mechanisms in malignancy. 2000;66-116 Springer, Heidelberg.
156. Janeway T.C. The clinical study of blood pressure. 1904;300 D. Appleton, New York.
157. Bartter F.C. Periodicity and medicine. Scheving L.E., Halberg F., Pauly J.E. Chronobiology. 1974;6-13 Igaku Shoin, Tokyo.
158. Schaffer E., Cornélissen G., Rhodus N., Halhuber M., Watanabe Y., Halberg F. Outcomes of chronobiologically normotensive dental patients: a 7-year follow-up. J Am Dent Assoc. 132:2001;891-899.
159. Goldstein L.B., Adams R., Becker K., et al. Primary prevention of ischemic stroke: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Circulation. 103:2001;163-182.
160. Grundy S.M., Pasternak R., Greenland P., Smith S. Jr., Fuster V. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation. 100:1999;1481-1492.
161. Cornélissen G., Schwartzkopff O., Halberg F., Otsuka K., Watanabe Y. 7-day ambulatory monitoring for adults with hypertension and diabetes. Am J Kidney Dis. 37:2001;878. Letter.